SCHEMBL7492525

SCHEMBL7492525

CCOC(=O)COc1cccc2c1CCCC2N1CCCC1c1nc(-c2ccc(C)cc2)c(-c2ccc(C)cc2)o1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 9/20 0.71
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
PTGDR Q13258 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
F2RL3 Q96RI0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7490049 0.95 PTGIR (0.79) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7483521 0.95 PTGIR (0.79) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7485719 0.95 PTGIR (0.79) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7485254 0.95 PTGIR (0.79) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7490127 0.95 PTGIR (0.79) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7494834 0.92 PTGIR (0.75) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7498945 0.92 PTGIR (0.74) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7494915 0.92 PTGIR (0.74) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7489789 0.92 PTGIR (0.76) PTGIRPTGDR
SCHEMBL7493823 0.89 PTGIR (0.71) PTGIRKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed